Proteolytic processing of the Alzheimer disease-associated presenilin-1 generates an in vivo substrate for protein kinase

被引:109
作者
Walter, J
Grunberg, J
Capell, A
Pesold, B
Schindzielorz, A
Citron, M
Mendla, K
StGeorgeHyslop, P
Multhaup, G
Selkoe, DJ
Haass, C
机构
[1] CENT INST MENTAL HLTH, DEPT BIOL MOL, D-68159 MANNHEIM, GERMANY
[2] BOEHRINGER INGELHEIM KG, DEPT BIOL RES, D-55126 INGELHEIM, GERMANY
[3] UNIV TORONTO, DEPT MED NEUROL, CTR RES NEURODEGENERAT DIS, TORONTO, ON M5S 1A8, CANADA
[4] CTR MOL BIOL, D-69120 HEIDELBERG, GERMANY
[5] HARVARD UNIV, BRIGHAM & WOMENS HOSP, SCH MED, CTR NEUROL DIS, BOSTON, MA 02115 USA
关键词
protein phosphorylation; muscarinic receptors; phorbol ester; signal transduction;
D O I
10.1073/pnas.94.10.5349
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The majority of familial Alzheimer disease mutations are linked to the recently cloned presenilin (PS) genes, which encode two highly homologous proteins (PS-1 and PS-2), It was shown that the full-length PS-2 protein is phosphorylated constitutively within its N-terminal domain by casein kinases, whereas the PS-1 protein is not. Full-Length PS proteins undergo endoproteolytic cleavage within their hydrophilic loop domain resulting in the formation of approximate to 20-kDa C-terminal fragments (CTF) and approximate to 30-kDa N-terminal fragments [Thinakaran, G., et al. (1996) Neuron 17, 181-190], Here we describe the surprising finding that the CTF of PS-1 is phosphorylated by protein kinase C (PKC), Stimulation of PKC causes a 4- to 5-fold increase of the phosphorylation of the approximate to 20-kDa CTF of PS-1 resulting in reduced mobility in SDS gels, PKC-stimulated phosphorylation occurs predominantly on serine residues and can be induced either by direct stimulation of PKC with phorbol-12,13-dibutyrate or by activation of the mi acetylcholine receptor-signaling pathway with the muscarinic agonist carbachol. However, phosphorylation of full-length PS-1 and PS-2 is not altered upon PRC stimulation, In addition, a mutant form of PS-1 lacking exon 10, which does not undergo endoproteolytic cleavage [Thinakaran, G., et al. (1996) Neuron 17, 181-190] is not phosphorylated by PKC, although it still contains all PKC phosphorylation sites conserved between different species, These results show that PKC phosphorylates the PS-1 CTF. Therefore, endoproteolytic cleavage of full-length PS-1 results in the generation of an in vivo substrate for PKC, The selective phosphorylation of the PS-1 CTF indicates that the physiological and/or pathological properties of the CTF are regulated by PKC activity.
引用
收藏
页码:5349 / 5354
页数:6
相关论文
共 47 条
  • [31] RELEASE OF ALZHEIMER AMYLOID PRECURSOR DERIVATIVES STIMULATED BY ACTIVATION OF MUSCARINIC ACETYLCHOLINE-RECEPTORS
    NITSCH, RM
    SLACK, BE
    WURTMAN, RJ
    GROWDON, JH
    [J]. SCIENCE, 1992, 258 (5080) : 304 - 307
  • [32] PEARSON RB, 1991, METHOD ENZYMOL, V200, P62
  • [33] PerezTur J, 1995, NEUROREPORT, V7, P297
  • [34] FAMILIAL ALZHEIMERS-DISEASE IN KINDREDS WITH MISSENSE MUTATIONS IN A GENE ON CHROMOSOME-1 RELATED TO THE ALZHEIMERS-DISEASE TYPE-3 GENE
    ROGAEV, EI
    SHERRINGTON, R
    ROGAEVA, EA
    LEVESQUE, G
    IKEDA, M
    LIANG, Y
    CHI, H
    LIN, C
    HOLMAN, K
    TSUDA, T
    MAR, L
    SORBI, S
    NACMIAS, B
    PIACENTINI, S
    AMADUCCI, L
    CHUMAKOV, I
    COHEN, D
    LANNFELT, L
    FRASER, PE
    ROMMENS, JM
    STGEORGEHYSLOP, PH
    [J]. NATURE, 1995, 376 (6543) : 775 - 778
  • [35] GENETIC DISSECTION OF ALZHEIMER-DISEASE, A HETEROGENEOUS DISORDER
    SCHELLENBERG, GD
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (19) : 8552 - 8559
  • [36] Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease
    Scheuner, D
    Eckman, C
    Jensen, M
    Song, X
    Citron, M
    Suzuki, N
    Bird, TD
    Hardy, J
    Hutton, M
    Kukull, W
    Larson, E
    LevyLahad, E
    Viitanen, M
    Peskind, E
    Poorkaj, P
    Schellenberg, G
    Tanzi, R
    Wasco, W
    Lannfelt, L
    Selkoe, D
    Younkin, S
    [J]. NATURE MEDICINE, 1996, 2 (08) : 864 - 870
  • [37] Evidence for phosphorylation and oligomeric assembly of presenilin 1
    Seeger, M
    Nordstedt, C
    Petanceska, S
    Kovacs, DM
    Gouras, GK
    Hahne, S
    Fraser, P
    Levesque, L
    Czernik, AJ
    StGeorgeHyslop, P
    Sisodia, SS
    Thinakaran, G
    Tanzi, RE
    Greengard, P
    Gandy, S
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (10) : 5090 - 5094
  • [38] Amyloid beta-protein and the genetics of Alzheimer's disease
    Selkoe, DJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (31) : 18295 - 18298
  • [39] NORMAL AND ABNORMAL BIOLOGY OF THE BETA-AMYLOID PRECURSOR PROTEIN
    SELKOE, DJ
    [J]. ANNUAL REVIEW OF NEUROSCIENCE, 1994, 17 : 489 - 517
  • [40] CLONING OF A GENE BEARING MISSENSE MUTATIONS IN EARLY-ONSET FAMILIAL ALZHEIMERS-DISEASE
    SHERRINGTON, R
    ROGAEV, EI
    LIANG, Y
    ROGAEVA, EA
    LEVESQUE, G
    IKEDA, M
    CHI, H
    LIN, C
    LI, G
    HOLMAN, K
    TSUDA, T
    MAR, L
    FONCIN, JF
    BRUNI, AC
    MONTESI, MP
    SORBI, S
    RAINERO, I
    PINESSI, L
    NEE, L
    CHUMAKOV, I
    POLLEN, D
    BROOKES, A
    SANSEAU, P
    POLINSKY, RJ
    WASCO, W
    DASILVA, HAR
    HAINES, JL
    PERICAKVANCE, MA
    TANZI, RE
    ROSES, AD
    FRASER, PE
    ROMMENS, JM
    STGEORGEHYSLOP, PH
    [J]. NATURE, 1995, 375 (6534) : 754 - 760